Developing Innovative Next-generation Targeted Radiotherapeutics for Cancer Patients

Cereius_Technology_Icon

Technology

Targeted radiotherapeutics (TRT) are precision medicines that deliver radiation to kill cancer cells. Our novel platform is based on a proprietary modular design to increase efficacy and safety by increasing delivery to tumors while sparing normal tissues.

Cereius_Pipeline_Icon

Pipeline

Cereius is developing a clinical pipeline to address both brain and peripheral solid tumors. CER-101 is our lead candidate designed to deliver targeted radiation to breast cancer brain metastases.

Cereius_Team_Icon

Team

Cereius is led by a team with a deep understanding of the biology of cancer and extensive drug discovery and development experience.

Cereius_Background_Icon

Background

Targeted radiotherapeutics combine the precision of targeted molecules with the power of radiation treatment. Read more about TRTs and the uses of radiation therapy.